About Morphle
Morphle is a company based in Bengaluru (India) founded in 2017. Morphle has raised $5.15 million across 3 funding rounds from investors including HealthVenture, Y Combinator and Inflexor. Morphle offers products and services including Robotic Microtome, MorphoLens 1, MorphoLens 6, MorphoLens 240, and HemoLens 16. Morphle operates in a competitive market with competitors including Akoya Biosciences, Scopio Labs, PreciPoint, Optra SCAN and Grundium, among others.
- Headquarter Bengaluru, India
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Morphle Labs Private Limited
- Date of Incorporation 08 Jan, 2020
- Jurisdiction Bangalore South, Karnataka, India
-
Annual Revenue
$1.33 M (USD)164.29as on Mar 31, 2023
-
Net Profit
-$10.57 K (USD)72.23as on Mar 31, 2023
-
EBITDA
$10.14 K (USD)133.24as on Mar 31, 2023
-
Total Equity Funding
$5.15 M (USD)
in 3 rounds
-
Latest Funding Round
$5 M (USD), Series A
Nov 25, 2025
-
Investors
HealthVenture
& 2 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Morphle
Morphle offers a comprehensive portfolio of products and services, including Robotic Microtome, MorphoLens 1, MorphoLens 6, MorphoLens 240, and HemoLens 16.
Automates tissue sectioning for high-throughput pathology
Scans single slides for tissue and cytology applications
Handles up to 100 slides daily for digital microscopy
Processes high-volume batches for histopathology workflows
Specialized for hematology and bone marrow analysis
People of Morphle
Unlock access to complete
Funding Insights of Morphle
Morphle has successfully raised a total of $5.15M across 3 strategic funding rounds. The most recent funding activity was a Series A round of $5 million completed in November 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Morphle
Morphle has secured backing from 3 investors, including venture fund investors. Prominent investors backing the company include HealthVenture, Y Combinator and Inflexor.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Healthcare focused incubator and VC firm
|
Locked | Locked | Locked | |
|
Early-stage startups are accelerated via funding and educational programs.
|
Locked | Locked | Locked | |
|
Venture capital firm investing in technology and deep tech startups with a focus on innovative solutions.
|
Locked | Locked | Locked |
Investor details for Morphle
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Morphle
Investment portfolio details for Morphle
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Morphle
Detailed financials for Morphle
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Morphle Comparisons
Peer comparison for Morphle
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Morphle
Morphle operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Akoya Biosciences, Scopio Labs, PreciPoint, Optra SCAN and Grundium, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Provider of solutions for rapid proteomic profiling
|
|
| Locked | Locked | Locked |
Provider of computational imaging-based digital microscopes & image analysis tools
|
|
| Locked | Locked | Locked |
Digital microscopes and micro-positioning systems are developed.
|
|
| Locked | Locked | Locked |
Integrated digital pathology solutions.
|
|
| Locked | Locked | Locked |
Portable scanning microscopes are supplied for medical researchers.
|
Detailed competitors of Morphle
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Morphle
Complete news archive for Morphle
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Morphle
Morphle was founded in 2017 and raised its 1st funding round 3 years after it was founded.
Morphle is headquartered in Bengaluru, India. It is registered at Bengaluru, Karnataka, India.
Morphle is a funded company, having raised a total of $5.15M across 3 funding rounds to date.
Annual revenue of Morphle is $1.33M as on Mar 31, 2023.
Provider of robotic microtomes and digital pathology scanners. These devices automate tissue processing and slide scanning for anatomical pathology, dermatopathology, and hematology. The scanners offer high-resolution imaging and integrated workflows, facilitating efficient digital microscopy and telepathology applications. Various models cater to different throughput needs, from single-slide to high-volume batch processing. The company also offers AI-powered requisition data entry solutions.
Morphle's top competitors include Akoya Biosciences, Optra SCAN and Scopio Labs.
Morphle offers Robotic Microtome, MorphoLens 1, MorphoLens 6, MorphoLens 240, and HemoLens 16.
Morphle has 3 investors. Key investors include HealthVenture, Y Combinator, and Inflexor.